You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molecular Conformation

Showing 1 - 25 of 5,005
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

Recruiting
  • CML, Chronic Phase
  • CML, Accelerated Phase
  • HS-10382(Part 1: Dose escalation)
  • HS-10382(Part 2: Dose expansion)
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Jan 12, 2023

Patients With Myocarditis

Not yet recruiting
  • Myocarditis
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Aug 17, 2023

    Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations

    Not yet recruiting
    • Gastrointestinal Stromal Tumors
    • +2 more
      • (no location specified)
      Jul 15, 2022

      COPD Trial in Brussels (Endoscopic lung volume reduction)

      Recruiting
      • COPD
      • Endoscopic lung volume reduction
      • Brussels, Belgium
        Erasme Hospital
      Mar 23, 2023

      Carcinoma, Adenoid Cystic, Head Neck Cancer Trial in Pavia (simultaneous integrated boost of carbon ions radiation therapy)

      Not yet recruiting
      • Carcinoma, Adenoid Cystic
      • Head and Neck Cancer
      • simultaneous integrated boost of carbon ions radiation therapy
      • Pavia, Italy
        CNAO
      Feb 8, 2023

      Advanced Malignant Tumor Trial in Guangzhou, Zhengzhou, Nanjing (TQB3915 tablets)

      Recruiting
      • Advanced Malignant Tumor
      • TQB3915 tablets
      • Guangzhou, Guangdong, China
      • +2 more
      Jun 9, 2022

      Keratoconus Trial in Teaneck (Corneal tissue inlay)

      Recruiting
      • Keratoconus
      • Corneal tissue inlay
      • Teaneck, New Jersey
        Cornea and Laser Eye Institue - Hersh Vision Group
      Mar 7, 2022

      Encephalopathy, Birth Defect, Intellectual Disability Trial in Fresno, Oakland, San Francisco (Whole Exome Sequencing)

      Completed
      • Encephalopathy
      • +9 more
      • Whole Exome Sequencing
      • Fresno, California
      • +3 more
      May 26, 2022

      Structural Anomalies, Cardiac Anomalies, CNS Anomalies Trial in San Francisco (Whole Exome Sequencing (WES))

      Completed
      • Structural Anomalies
      • +7 more
      • Whole Exome Sequencing (WES)
      • San Francisco, California
        University of California San Francisco
      Jun 14, 2022

      Infections in Lung Transplantation

      Recruiting
      • Lung Transplant Infection
      • +4 more
      • BioFire Pneumonia Panel Plus
      • Milano, Italy
        Irccs Fondazione Ca' Granda Policlinico Di Milano
      Jul 17, 2023

      Traumatic Brain Injury Trial in Cairo (Cerebrolysin, amantadine sulfate)

      Recruiting
      • Traumatic Brain Injury
      • Cairo, Egypt
        Faculty of medicine - Ain shams university
      Sep 26, 2023

      Aortoiliac Occlusive Disease, Stent Complication, Vascular Device Occlusion Trial in Valladolid (Aortoiliac angioplasty and

      Completed
      • Aortoiliac Occlusive Disease
      • +3 more
      • Aortoiliac angioplasty and stenting
      • Valladolid, Spain
        Valladolid Univeristy Hospital
      Aug 21, 2023

      Cancer Trial in Berlin

      Recruiting
      • Cancer
        • Berlin, Germany
          Charité Comprehensive Cancer Center
        Jun 21, 2023

        A Retrospective Study on Multiple Classifier Endometrial Cancer

        Recruiting
        • Uterine Cancer
        • Observation only
        • Milan, Italy
          Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
        Jul 27, 2023

        FSHD Molecular Characterization

        Recruiting
        • Facio-Scapulo-Humeral Dystrophy
          • Columbus, Ohio
            The Abigail Wexner Research Institute at Nationwide Children's H
          Oct 20, 2023

          Rare Cancers, Multiomics Trial in Heidelberg

          Recruiting
          • Rare Cancers
          • Multiomics
            • Heidelberg, Germany
              German Cancer Research Center
            May 2, 2023

            Anticoagulant, Venous Thromboembolism, Prophylaxis Trial in Denmark (Dalteparin Prefilled Syringe, Tinzaparin profiled syringe)

            Recruiting
            • Anticoagulant
            • +3 more
            • Dalteparin Prefilled Syringe
            • Tinzaparin profiled syringe
            • Copenhagen, Denmark
            • +8 more
            Aug 29, 2023

            Determining Individualized Cancer Therapy in Pancreatic Cancer

            Not yet recruiting
            • Pancreatic Neoplasms
            • Targeted Therapy
            • Milwaukee, Wisconsin
              Froedtert Hospital and the Medical College of Wisconsin
            Jun 14, 2023

            Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

            Not yet recruiting
            • Renal Cell Carcinoma
            • Pembrolizumab injection
            • Birmingham, Alabama
              University of Alabama at Birmingham
            Aug 20, 2023

            Stage III Solid Tumors, Stage IV Solid Tumors Trial (Comprehensive molecular panel test, EORTC QLQ-30)

            Not yet recruiting
            • Stage III Solid Tumors
            • Stage IV Solid Tumors
            • Comprehensive molecular panel test
            • EORTC QLQ-30
            • (no location specified)
            Jan 25, 2023

            Rare Malignant Tumor Trial (Imatinib)

            Not yet recruiting
            • Rare Malignant Neoplasm
            • (no location specified)
            Nov 1, 2023

            Dialysis; Complications, Bleeding Trial in Wonju (Nafamostat Mesylate)

            Recruiting
            • Dialysis; Complications
            • Bleeding
            • Nafamostat Mesylate
            • Wonju, Kangwondo, Korea, Republic of
              Yonsei Unviersity Wonju College of Medicin
            May 22, 2023

            CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

            Recruiting
            • CML
            • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
            • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
              FUNDALEU
            Jun 29, 2023

            Solid Tumor, Leukemia Trial in Paris (Solid tumor and CT DNA)

            Recruiting
            • Solid Tumor
            • Leukemia
            • Solid tumor and CT DNA
            • Paris, Villejuif, France
              Gustave Roussy
            Jan 19, 2023

            Corresponding to Different Molecular Subtypes of Brest Cancer. A

            Completed
            • Breast Cancer
              • (no location specified)
              Feb 24, 2023